BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Arteriocyte, Inc. 

11000 Cedar Avenue

Cleveland  Ohio  44106  U.S.A.
Phone: 216-658-3970 Fax: 216-229-7323


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology


Collaborations

Center for Stem Cell and Regenerative Medicine  (CSCRM startup company) is an early-stage company developing proprietary stem cell based therapies to grow new blood vessels for patients with a variety of vascular diseases.





 Company News
Arteriocyte, Inc. Awarded BARDA Contract Valued up to $101.1 Million for Advanced Development of Arteriocyte's Magellan® BioBandage™ for Thermal Radiation Injury 9/26/2013 10:25:34 AM    More...
Arteriocyte, Inc. Receives FDA Approval to Initiate Cellular Therapy Trial for Treatment of Thermal Burn Wounds in Wounded Warriors 1/31/2013 9:21:59 AM    More...
National Institutes of Health (NIH) Awards Grant to Arteriocyte, Inc. and Its Collaboration With the University of Utah and Dana Farber to Develop Its NANEX™ Technology for Use in Bone Marrow Transplant 8/23/2012 10:45:16 AM    More...
Arteriocyte, Inc. Receives FDA Approval to Initiate Compartment Syndrome Trial for Amputation Prevention Focused on Wounded Warriors 4/4/2012 9:49:58 AM    More...
Arteriocyte, Inc. Receives $1 Million Award From Ohio Third Frontier Program to Advance Its NANEX™ Technology Toward Clinical Use 7/20/2011 11:31:24 AM    More...
Arteriocyte, Inc. and the U.S. Army Institute of Surgical Research (USAISR) Sign a CRADA to Speed Development of Cellular Therapies for Orthopaedic Trauma 6/7/2011 11:28:35 AM    More...
Arteriocyte, Inc. Receives FDA Approval to Move Forward with Critical Limb Ischemia Trial 1/28/2011 9:19:42 AM    More...
Arteriocyte, Inc. Announces the Launch of NANEX(TM) Stem Cell Expansion System at the Upcoming American Society for Cell Biology Meeting 12/2/2010 11:25:46 AM    More...
Arteriocyte, Inc. Named Top Biotech Start Up Venture by the Ohio Venture Association for 2010 6/28/2010 9:21:25 AM    More...
Arteriocyte, Inc. Wins $4.99 Million in Grant Money 5/1/2009 8:12:22 AM    More...
12